Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 94 articles:
HTML format
Text format



Single Articles


    February 2017
  1. CAINI S, Masala G, Saieva C, Kvaskoff M, et al
    Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2017 Feb 20. doi: 10.1002/ijc.30659.
    PubMed     Text format     Abstract available


  2. DE VRIES E, Amador JR, Rincon CJ, Uribe C, et al
    Cutaneous Melanoma Attributable to Solar Radiation in Cali, Colombia.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30638.
    PubMed     Text format     Abstract available


  3. LIN Y, Chahal HS, Wu W, Cho HG, et al
    Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma.
    Int J Cancer. 2017 Feb 8. doi: 10.1002/ijc.30634.
    PubMed     Text format     Abstract available


  4. PARK SM, Li T, Wu S, Li WQ, et al
    Niacin intake and risk of skin cancer in US women and men.
    Int J Cancer. 2017 Feb 2. doi: 10.1002/ijc.30630.
    PubMed     Text format     Abstract available


    January 2017
  5. HALONEN PM, Jakobsson MI, Oskari Heikinheimo MA, Riska AE, et al
    Lichen sclerosus and risk of cancer.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30621.
    PubMed     Text format     Abstract available


  6. OUDE OPHUIS CM, Louwman MW, Grunhagen DJ, Verhoef C, et al
    Implementation of the 7th Edition AJCC Staging System: Effects on Staging and Survival for pT1 Melanoma. A Dutch Population Based Study.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30607.
    PubMed     Text format     Abstract available


  7. POTRONY M, Rebollo-Morell A, Gimenez-Xavier P, Zimmer L, et al
    IRF4 rs12203592 functional variant and melanoma survival.
    Int J Cancer. 2017 Jan 19. doi: 10.1002/ijc.30605.
    PubMed     Text format     Abstract available


    December 2016
  8. SHEN J, Song R, Wan J, Huff C, et al
    Global methylation of blood leukocyte DNA and risk of melanoma.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30577.
    PubMed     Text format     Abstract available


  9. BAUM C, Weiss C, Gebhardt C, Utikal J, et al
    Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
    Int J Cancer. 2016 Dec 9. doi: 10.1002/ijc.30563.
    PubMed     Text format     Abstract available


  10. LI H, Wang Y, Liu H, Shi Q, et al
    Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
    Int J Cancer. 2016 Dec 3. doi: 10.1002/ijc.30545.
    PubMed     Text format     Abstract available


    November 2016
  11. HEGEDUS L, Garay T, Molnar E, Varga K, et al
    The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells.
    Int J Cancer. 2016 Nov 4. doi: 10.1002/ijc.30503.
    PubMed     Text format     Abstract available


  12. DESCH A, Gebhardt C, Utikal J, Schneider SW, et al
    D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
    Int J Cancer. 2016 Nov 3. doi: 10.1002/ijc.30498.
    PubMed     Text format     Abstract available


    September 2016
  13. DING Z, Xu W, Zhang J, Zou W, et al
    Normalizing GDNF Expression in the Spinal Cord Alleviates Cutaneous Hyperalgesia but not Ongoing Pain in a Rat Model of Bone Cancer Pain.
    Int J Cancer. 2016 Sep 22. doi: 10.1002/ijc.30438.
    PubMed     Text format     Abstract available


  14. SARRABAYROUSE G, Pich C, Teiti I, Tilkin-Mariame AF, et al
    Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30422.
    PubMed     Text format     Abstract available


    August 2016
  15. ZHANG W, Liu H, Yin J, Wu W, et al
    Genetic Variants in the PIWI-piRNA Pathway Gene DCP1A Predict Melanoma Disease-specific Survival.
    Int J Cancer. 2016 Aug 31. doi: 10.1002/ijc.30409.
    PubMed     Text format     Abstract available


  16. ROCKBERG J, Amelio JM, Taylor A, Jorgensen L, et al
    Epidemiology of cutaneous melanoma in Sweden - stage specific survival and rate of recurrence.
    Int J Cancer. 2016 Aug 26. doi: 10.1002/ijc.30407.
    PubMed     Text format     Abstract available


  17. LI WQ, Cho E, Han J, Weinstock MA, et al
    Male pattern baldness and risk of incident skin cancer in a cohort of men.
    Int J Cancer. 2016 Aug 20. doi: 10.1002/ijc.30395.
    PubMed     Text format     Abstract available


    July 2016
  18. MISHRA S, Tewari P, Chaudhari BP, Dwivedi PD, et al
    Deoxynivalenol induced mouse skin tumor initiation: Elucidation of molecular mechanisms in Human Hacat keratinocytes.
    Int J Cancer. 2016 Jul 8. doi: 10.1002/ijc.30260.
    PubMed     Text format     Abstract available


  19. INOUE K, Fry EA
    Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.
    Int J Cancer. 2016;139:33-41.
    PubMed     Text format     Abstract available


    June 2016
  20. VAYSSE A, Fang S, Brossard M, Wei Q, et al
    A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants.
    Int J Cancer. 2016 Jun 27. doi: 10.1002/ijc.30245.
    PubMed     Text format     Abstract available


  21. MAXWELL R, Garzon-Muvdi T, Lipson EJ, Sharfman WH, et al
    BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30241.
    PubMed     Text format     Abstract available


  22. GRAUL-CONROY A, Hicks EJ, Fahl WE
    Equivalent chemotherapy efficacy against leukemia in mice treated with topical vasoconstrictors to prevent cancer therapy side effects.
    Int J Cancer. 2016;138:3011-9.
    PubMed     Text format     Abstract available


  23. MIRZAEI H, Naseri G, Rezaee R, Mohammadi M, et al
    Curcumin: A new candidate for melanoma therapy?
    Int J Cancer. 2016 Jun 9. doi: 10.1002/ijc.30224.
    PubMed     Text format     Abstract available


  24. LIU X, Li J, Qu X, Yan W, et al
    Treatment of kaposiform hemangioendothelioma and tufted angioma.
    Int J Cancer. 2016 Jun 2. doi: 10.1002/ijc.30216.
    PubMed     Text format     Abstract available


  25. GANDINI S, Ferrucci PF, Botteri E, Tosti G, et al
    Prognostic significance of hematological profiles in melanoma patients.
    Int J Cancer. 2016 Jun 2. doi: 10.1002/ijc.30215.
    PubMed     Text format     Abstract available


  26. BRAILLON A, Campergue R
    Screening mammography: There is a golden mammoth in the room!
    Int J Cancer. 2016;138:2762.
    PubMed     Text format    


    May 2016
  27. ORTEGA-MARTINEZ I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, et al
    Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early stage melanoma.
    Int J Cancer. 2016 May 23. doi: 10.1002/ijc.30202.
    PubMed     Text format     Abstract available


  28. HATEM R, Labiod D, Chateau-Joubert S, de Plater L, et al
    Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers.
    Int J Cancer. 2016;138:2510-21.
    PubMed     Text format     Abstract available


  29. POTRONY M, Carreras E, Aranda F, Zimmer L, et al
    Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival.
    Int J Cancer. 2016 May 11. doi: 10.1002/ijc.30184.
    PubMed     Text format     Abstract available


    April 2016
  30. TAYLOR NJ, Thomas NE, Anton-Culver H, Armstrong BK, et al
    Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.
    Int J Cancer. 2016 Apr 22. doi: 10.1002/ijc.30157.
    PubMed     Text format     Abstract available


  31. SMALLEY KS, Fedorenko IV, Kenchappa R, Sahebjam S, et al
    Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30147.
    PubMed     Text format     Abstract available


  32. UBILLOS L, Freire T, Berriel E, Chiribao ML, et al
    Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.
    Int J Cancer. 2016;138:1719-31.
    PubMed     Text format     Abstract available


    March 2016
  33. SIMBERG-DANELL C, Lyth J, Mansson-Brahme E, Frohm-Nilsson M, et al
    Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
    Int J Cancer. 2016 Mar 23. doi: 10.1002/ijc.30103.
    PubMed     Text format     Abstract available


  34. ROWE CJ, Tang F, Hughes MC, Rodero MP, et al
    Molecular markers to complement sentinel node status in predicting survival in patients with high risk locally invasive melanoma.
    Int J Cancer. 2016 Mar 14. doi: 10.1002/ijc.30085.
    PubMed     Text format     Abstract available


  35. SCHRAMA D, Hesbacher S, Angermeyer S, Schlosser A, et al
    Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cells.
    Int J Cancer. 2016;138:1153-62.
    PubMed     Text format     Abstract available


    February 2016
  36. RAIMONDI S, Botteri E, Munzone E, Cipolla C, et al
    Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30062.
    PubMed     Text format     Abstract available


  37. MANIE E, Popova T, Battistella A, Tarabeux J, et al
    Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas.
    Int J Cancer. 2016;138:891-900.
    PubMed     Text format     Abstract available


  38. NAGORE E, Heidenreich B, Rachakonda S, Garcia-Casado Z, et al
    TERT promoter mutations in melanoma survival.
    Int J Cancer. 2016 Feb 13. doi: 10.1002/ijc.30042.
    PubMed     Text format     Abstract available


  39. DEVARAPU SK, Mamidi S, Ploger F, Dill O, et al
    Cytotoxic Activity Against Human Neuroblastoma and Melanoma Cells Mediated by IgM Antibodies Derived from Peripheral Blood of Healthy Donors.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30025.
    PubMed     Text format     Abstract available


  40. VARADAN V, Kamalakaran S, Gilmore H, Banerjee N, et al
    Brief-exposure to preoperative bevacizumab reveals a TGF-beta signature predictive of response in HER2-negative breast cancers.
    Int J Cancer. 2016;138:747-57.
    PubMed     Text format     Abstract available


    January 2016
  41. ERIKSSON H, Lyth J, Andersson TM
    The proportion cured of patients diagnosed with stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
    Int J Cancer. 2016 Jan 27. doi: 10.1002/ijc.30023.
    PubMed     Text format     Abstract available


  42. HARRIS HR, Bergkvist L, Wolk A
    Adherence to the world cancer research fund/american institute for cancer research recommendations and breast cancer risk.
    Int J Cancer. 2016 Jan 25. doi: 10.1002/ijc.30015.
    PubMed     Text format     Abstract available


  43. DARTOIS L, Fagherazzi G, Baglietto L, Boutron-Ruault MC, et al
    Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29987.
    PubMed     Text format     Abstract available


  44. NOMURA SJ, Inoue-Choi M, Lazovich D, Robien K, et al
    WCRF/AICR recommendation adherence and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29994.
    PubMed     Text format     Abstract available


  45. WOODS LM, Rachet B, O'Connell DL, Lawrence G, et al
    Are international differences in breast cancer survival between Australia and England present amongst both screen-detected women and non-screen-detected women? Survival estimates for women diagnosed in West Midlands and New South Wales 1997-2006.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29984.
    PubMed     Text format     Abstract available


  46. WOODS LM, Rachet B, O'Connell D, Lawrence G, et al
    Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29983.
    PubMed     Text format     Abstract available


  47. CASEY MC, Sweeney KJ, Andrew Lawrence Brown J, Kerin MJ, et al
    Exploring circulating microRNA in the Neoadjuvant Treatment of Breast Cancer.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29985.
    PubMed     Text format     Abstract available


    December 2015
  48. PENG C, Wallwiener M, Rudolph A, Cuk K, et al
    Plasma Hyaluronic Acid level as a Prognostic and Monitoring Marker of Metastatic Breast Cancer.
    Int J Cancer. 2015 Dec 19. doi: 10.1002/ijc.29975.
    PubMed     Text format     Abstract available


  49. OROUJI E, Orouji A, Gaiser T, Larribere L, et al
    MAP Kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma.
    Int J Cancer. 2015 Dec 18. doi: 10.1002/ijc.29970.
    PubMed     Text format     Abstract available


  50. SISTI JS, Collins LC, Beck AH, Tamimi RM, et al
    Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the Nurses' Health Studies.
    Int J Cancer. 2015 Dec 18. doi: 10.1002/ijc.29968.
    PubMed     Text format     Abstract available


  51. CAI H, Zhang Y, Han TK, Everett RS, et al
    Cation-selective transporters are critical to the ampk-mediated antiproliferative effects of metformin in human breast cancer cells.
    Int J Cancer. 2015 Dec 15. doi: 10.1002/ijc.29965.
    PubMed     Text format     Abstract available


  52. THOMSEN FB, Folkvaljon Y, Garmo H, Robinson D, et al
    Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study.
    Int J Cancer. 2015 Dec 14. doi: 10.1002/ijc.29961.
    PubMed     Text format     Abstract available


  53. YAO S, Haddad SA, Hu Q, Liu S, et al
    Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER Consortium.
    Int J Cancer. 2015 Dec 9. doi: 10.1002/ijc.29954.
    PubMed     Text format     Abstract available


  54. NABHOLTZ JM, Chalabi N, Radosevic-Robin N, Dauplat MM, et al
    Multicentric neoadjuvant pilot phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.
    Int J Cancer. 2015 Dec 9. doi: 10.1002/ijc.29952.
    PubMed     Text format     Abstract available


  55. OBI N, Heinz J, Seibold P, Vrieling A, et al
    Relationship between menopausal hormone therapy and mortality after breast cancer.
    Int J Cancer. 2015 Dec 9. doi: 10.1002/ijc.29951.
    PubMed     Text format     Abstract available


  56. PRECA BT, Bajdak K, Mock K, Sundararajan V, et al
    A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
    Int J Cancer. 2015;137:2566-77.
    PubMed     Text format     Abstract available


  57. FIELD S, Uyttenhove C, Stroobant V, Cheou P, et al
    Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer.
    Int J Cancer. 2015 Dec 1. doi: 10.1002/ijc.29946.
    PubMed     Text format     Abstract available


    November 2015
  58. NECHUTA S, Chen WY, Cai H, Poole EM, et al
    A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor positive breast cancer prognosis.
    Int J Cancer. 2015 Nov 25. doi: 10.1002/ijc.29940.
    PubMed     Text format     Abstract available


  59. SALAGAME U, Banks E, Sitas F, Canfell K, et al
    Menopausal Hormone Therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer Lifestyle and EvAluation of Risk (CLEAR) study.
    Int J Cancer. 2015 Nov 24. doi: 10.1002/ijc.29942.
    PubMed     Text format     Abstract available


  60. CAO Y, Hou L, Wang W
    Dietary total fat and fatty acids intake, serum fatty acids and risk of breast cancer: A meta-analysis of prospective cohort studies.
    Int J Cancer. 2015 Nov 23. doi: 10.1002/ijc.29938.
    PubMed     Text format     Abstract available


  61. HIRAGA T, Ito S, Nakamura H
    EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
    Int J Cancer. 2015 Nov 18. doi: 10.1002/ijc.29921.
    PubMed     Text format     Abstract available


  62. BLEYER A, Baines C, Miller AB
    Impact of Screening Mammography on Breast Cancer Mortality.
    Int J Cancer. 2015 Nov 12. doi: 10.1002/ijc.29925.
    PubMed     Text format     Abstract available


  63. BANERJEE K, Resat H
    Constitutive activation of STAT3 in breast cancer cells: A review.
    Int J Cancer. 2015 Nov 11. doi: 10.1002/ijc.29923.
    PubMed     Text format     Abstract available


  64. RIPPING TM, Hubbard RA, Otten JD, den Heeten GJ, et al
    Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer.
    Int J Cancer. 2015 Nov 4. doi: 10.1002/ijc.29912.
    PubMed     Text format     Abstract available


    October 2015
  65. LIN W, Ren FM, Ren ZF
    The contribution of radiotherapy to subsequent thyroid cancer risk may be confined to a subgroup of breast cancer patients.
    Int J Cancer. 2015 Oct 30. doi: 10.1002/ijc.29907.
    PubMed     Text format    


  66. SUN LM, Lin CL, Liang JA, Kao CH, et al
    Authors' reply to Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study.
    Int J Cancer. 2015 Oct 30. doi: 10.1002/ijc.29906.
    PubMed     Text format    


  67. INOUE-CHOI M, Sinha R, Gierach GL, Ward MH, et al
    Red and processed meat, nitrite, and heme iron intakes and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study.
    Int J Cancer. 2015 Oct 27. doi: 10.1002/ijc.29901.
    PubMed     Text format     Abstract available


  68. SANKATSING VD, Heijnsdijk EA, van Luijt PA, van Ravesteyn NT, et al
    Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
    Int J Cancer. 2015;137:1990-9.
    PubMed     Text format     Abstract available


    September 2015
  69. KOH M, Yong HY, Kim ES, Son H, et al
    A Novel Role for Flotillin-1 in H-Ras-regulated Breast Cancer Aggressiveness.
    Int J Cancer. 2015 Sep 28. doi: 10.1002/ijc.29869.
    PubMed     Text format     Abstract available


  70. HIRKO KA, Chen WY, Willett WC, Rosner BA, et al
    Alcohol consumption and risk of breast cancer by molecular subtype: prospective analysis of the Nurses' Health Study after 26 years of follow-up.
    Int J Cancer. 2015 Sep 18. doi: 10.1002/ijc.29861.
    PubMed     Text format     Abstract available


  71. FANG J, Xiao L, Joo KI, Liu Y, et al
    A Potent Immunotoxin Targeting Fibroblast Activation Protein for Treatment of Breast Cancer in Mice.
    Int J Cancer. 2015 Sep 3. doi: 10.1002/ijc.29831.
    PubMed     Text format     Abstract available


    August 2015
  72. ROMAN M, Sakshaug S, Graff-Iversen S, Vangen S, et al
    Postmenopausal hormone therapy and the risk of breast cancer in Norway.
    Int J Cancer. 2015 Aug 20. doi: 10.1002/ijc.29810.
    PubMed     Text format     Abstract available


  73. PARADA H, Wolff MS, Engel LS, White AJ, et al
    Organochlorine insecticides DDT and chlordane in relation to survival following breast cancer.
    Int J Cancer. 2015 Aug 18. doi: 10.1002/ijc.29806.
    PubMed     Text format     Abstract available


  74. MURILLO R, Diaz S, Perry F, Poveda C, et al
    Increased breast cancer screening and down-staging in Colombian women: A randomized trial of opportunistic breast-screening.
    Int J Cancer. 2015 Aug 11. doi: 10.1002/ijc.29801.
    PubMed     Text format     Abstract available


  75. WANG Y, Xu Y, Chen J, Ouyang T, et al
    TP53 Mutations Are Associated with Higher Rates of Pathologic Complete Response to Anthracycline/Cyclophosphamide-Based Neoadjuvant Chemotherapy in Operable Primary Breast Cancer.
    Int J Cancer. 2015 Aug 3. doi: 10.1002/ijc.29715.
    PubMed     Text format     Abstract available


    July 2015
  76. THORAT MA
    Sentinel lymph node assessment in breast cancer patients receiving neo-adjuvant chemotherapy: to biopsy before or after?
    Int J Cancer. 2015 Jul 30. doi: 10.1002/ijc.29692.
    PubMed     Text format    


  77. PARTIPILO G, Simone G, Scattone A, Scarpi E, et al
    Expression of proteins involved in DNA damage response in familial and sporadic breast cancer patients.
    Int J Cancer. 2015 Jul 23. doi: 10.1002/ijc.29699.
    PubMed     Text format     Abstract available


  78. AGRAWAL A, Robertson JF, Cheung KL, Gutteridge E, et al
    Biological effects of fulvestrant on estrogen receptor positive human breast cancer: Short, medium and long-term effects based on sequential biopsies.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29682.
    PubMed     Text format     Abstract available


  79. BRUNO E, Gargano G, Villarini A, Traina A, et al
    Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patients.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29689.
    PubMed     Text format     Abstract available


  80. GYORFFY B, Bottai G, Fleischer T, Munkacsy G, et al
    Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29684.
    PubMed     Text format     Abstract available


  81. REN C, Han C, Fu D, Wang D, et al
    Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29679.
    PubMed     Text format     Abstract available


  82. KIYABU GY, Inoue M, Saito E, Abe SK, et al
    Fish, n-3 polyunsaturated fatty acids, and n-6 polyunsaturated fatty acids intake and breast cancer risk: the Japan Public Health Center-based (JPHC) prospective Study.
    Int J Cancer. 2015 Jul 2. doi: 10.1002/ijc.29672.
    PubMed     Text format     Abstract available


  83. SUN LM, Lin CL, Liang JA, Huang WS, et al
    Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study.
    Int J Cancer. 2015 Jul 1. doi: 10.1002/ijc.29667.
    PubMed     Text format     Abstract available


    June 2015
  84. HEIN A, Lambrechts D, von Minckwitz G, Haberle L, et al
    Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase 3 GeparQuinto study.
    Int J Cancer. 2015 Jun 23. doi: 10.1002/ijc.29656.
    PubMed     Text format     Abstract available


  85. MOCELLIN S, Goldin E, Marchet A, Nitti D, et al
    Sentinel node biopsy performance after neoadjuvant chemotherapy in locally advanced breast cancer: A systematic review and meta-analysis.
    Int J Cancer. 2015 Jun 17. doi: 10.1002/ijc.29644.
    PubMed     Text format     Abstract available


    May 2015
  86. BHOO-PATHY N, Verkooijen HM, Wong FY, Pignol JP, et al
    Prognostic role of adjuvant radiotherapy in triple negative breast cancer: a historical cohort study.
    Int J Cancer. 2015 May 27. doi: 10.1002/ijc.29617.
    PubMed     Text format     Abstract available


  87. HEINONEN H, Lepikhova T, Sahu B, Pehkonen H, et al
    Identification of several potential chromatin binding sites of HOXB7 and its downstream target genes in breast cancer.
    Int J Cancer. 2015 May 26. doi: 10.1002/ijc.29616.
    PubMed     Text format     Abstract available


  88. SEFRIOUI D, Perdrix A, Sarafan-Vasseur N, Dolfus C, et al
    Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer.
    Int J Cancer. 2015 May 20. doi: 10.1002/ijc.29612.
    PubMed     Text format     Abstract available


  89. BOCCARDO F, Rubagotti A, Nuzzo PV, Argellati F, et al
    Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum Angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery.
    Int J Cancer. 2015 May 20. doi: 10.1002/ijc.29609.
    PubMed     Text format     Abstract available


    April 2015
  90. OH JK, Sandin S, Strom P, Lof M, et al
    Prospective study of breast cancer in relation to coffee, tea, and caffeine in Sweden.
    Int J Cancer. 2015 Apr 17. doi: 10.1002/ijc.29569.
    PubMed     Text format     Abstract available


  91. CHIOVARO F, Martina E, Bottos A, Scherberich A, et al
    Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
    Int J Cancer. 2015 Apr 13. doi: 10.1002/ijc.29565.
    PubMed     Text format     Abstract available


  92. KUMLER I, Balslev E, Poulsen TS, Nielsen SL, et al
    Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer.
    Int J Cancer. 2015 Apr 8. doi: 10.1002/ijc.29556.
    PubMed     Text format     Abstract available


    February 2015
  93. ROMIEU I, Scoccianti C, Chajes V, de Batlle J, et al
    Alcohol intake and breast cancer in the European Prospective investigation into Cancer and Nutrition: Short title: Alcohol intake and breast cancer: Alcohol intake and breast cancer.
    Int J Cancer. 2015 Feb 9. doi: 10.1002/ijc.29469.
    PubMed     Text format     Abstract available


    January 2015
  94. BARRDAHL M, Canzian F, Lindstrom S, Shui I, et al
    Association of breast cancer risk loci with breast cancer survival.
    Int J Cancer. 2015 Jan 21. doi: 10.1002/ijc.29446.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: